FIELD: pharmacology.
SUBSTANCE: pharmaceutical composition for hyperlipidemia treatment comprises a mixture of a glycyrrhizic derivative selected from glycyrrhizic acid and a pharmaceutically acceptable salt thereof, and a hypolipidemic drug-statin selected from atorvastatin, lovastatin, rosuvastatin, simvastatin, pravastatin, pitavastatin, fluvastatin and pharmaceutically acceptable salts or mixtures thereof, and auxiliary substances.
EFFECT: increased efficiency of the composition application.
24 cl, 36 tbl, 2 ex
Authors
Dates
2017-06-29—Published
2014-11-10—Filed